Rare lobular capillary hemangioma associated with azacitidine in high-risk myelodysplastic syndrome patient

Dermatol Ther. 2021 Mar;34(2):e14884. doi: 10.1111/dth.14884. Epub 2021 Feb 25.

Authors

Katerina Grafanaki^{1

2}, Alexandra Kourakli³, Ilias Skeparnias², Theofanis Spiliopoulos¹, Dimitra Koumoundourou⁴, Vasiliki Bravou⁴, Angelos Alexopoulos³, Argiris Symeonidis³, Sophia Georgiou¹

Affiliations

¹ Department of Dermatology, University Hospital of Patras, School of Medicine, University of Patras, Patras, Greece.
² Department of Biochemistry, School of Medicine, University of Patras, Patras, Greece.
³ Hematology Division, Department of Internal Medicine, University Hospital of Patras, School of Medicine, Patras, Greece.
⁴ Department of Anatomy-Histology-Embryology, School of Medicine, University of Patras, Patras, Greece.

PMID: 33594760
DOI: 10.1111/dth.14884

No abstract available

Publication types

Letter

MeSH terms

Antimetabolites, Antineoplastic / therapeutic use
Azacitidine / therapeutic use
Granuloma, Pyogenic*
Humans
Myelodysplastic Syndromes* / diagnosis
Myelodysplastic Syndromes* / drug therapy

Substances

Antimetabolites, Antineoplastic
Azacitidine